Sale

Chronic Renal Failure Therapeutic Market

Global Chronic Renal Failure Therapeutic Market Size, Report: By Product: Antihypertensive Therapeutics, Antianemia Therapeutics, Others, Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Indicators for Demand, Key Indicators for Price; Competitive Landscape; 2024-2032

Global Chronic Renal Failure Therapeutic Market Outlook

The global chronic renal failure therapeutic market size is expected to grow at a CAGR of 6% in the forecast period of 2024-2032. The industry has witnessed a substantial growth in the recent years across the world in both developing and developed countries.

 

Global Chronic Renal Failure Therapeutic Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Segmentation

Chronic kidney failure or chronic renal failure involves the loss of kidney functions over a prolonged period of time as opposed to acute renal failure. Stage 6 is for patients with a glomerular filtration rate of less than 15 mL per minute. For their renal failure, dialysis intervention is required.

 

Global Chronic Renal Failure Therapeutic Market By Product

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF


 
The industry can be divided based on segments like the product types and regions. The industry can be broadly categorised on the basis of product into:

  • Antihypertensive Therapeutics
  • Antianaemia Therapeutics
  • Others

The EMR report looks into the regional markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Chronic Renal Failure Therapeutic Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

Cardiovascular and metabolic conditions are the major risk factors for chronic renal failure. The increased prevalence of these risk factors leads to a significant increase in chronic renal disease incidence. Most of the market for this disorder is from the geriatric population in the United States, Europe, and Asia. Throughout the forecast period, the growing prevalence of chronic renal failure will consequently increase the growth prospects of the industry for chronic renal failure therapeutic. Developing novel inhibitors of hypoxia-inducible factor prolyl hydroxylase (HIF-PH) will also accelerate the industry growth for chronic renal failure therapies. For patients without haemodialysis, oral administration of HIF-PH drugs is preferable. Such factors raise the demand for these medications, leading to the expansion of the global therapeutic market for chronic renal failure.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global chronic renal failure therapeutic market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Amgen Inc. (NASDAQ: AMGN)
  • AstraZeneca Plc
  • F. Hoffmann-La Roche Ltd.
  • Bayer AG
  • Pfizer Inc.
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Region
Breakup by Product
  • Antihypertensive therapeutics
  • Antianaemia Therapeutics
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach an
Companies Covered
  • Amgen Inc. 
  • AstraZeneca Plc
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd.
  • Bayer AG
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Chronic Renal Failure Therapeutic Market Analysis
    8.1    Key Industry Highlights
    8.2    Global Chronic Renal Failure Therapeutic Historical Market (2018-2023) 
    8.3    Global Chronic Renal Failure Therapeutic Market Forecast (2024-2032)
    8.4    Global Chronic Renal Failure Therapeutic Market by Product
        8.4.1    Antihypertensive Therapeutics
            8.4.1.1    Historical Trend (2018-2023)
            8.4.1.2    Forecast Trend (2024-2032)
        8.4.2    Antianemia Therapeutics
            8.4.2.1    Historical Trend (2018-2023)
            8.4.2.2    Forecast Trend (2024-2032)
        8.4.3    Others
    8.5    Global Chronic Renal Failure Therapeutic Market by Region     
        8.5.1    North America
            8.5.1.1    Historical Trend (2018-2023) 
            8.5.1.2    Forecast Trend (2024-2032)
        8.5.2    Europe
            8.5.2.1    Historical Trend (2018-2023) 
            8.5.2.2    Forecast Trend (2024-2032)
        8.5.3    Asia Pacific
            8.5.3.1    Historical Trend (2018-2023) 
            8.5.3.2    Forecast Trend (2024-2032)
        8.5.4    Latin America
            8.5.4.1    Historical Trend (2018-2023) 
            8.5.4.2    Forecast Trend (2024-2032)
        8.5.5    Middle East and Africa
            8.5.5.1    Historical Trend (2018-2023) 
            8.5.5.2    Forecast Trend (2024-2032)
9    North America Chronic Renal Failure Therapeutic Market Analysis
    9.1    United States of America 
        9.1.1    Historical Trend (2018-2023) 
        9.1.2    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Historical Trend (2018-2023) 
        9.2.2    Forecast Trend (2024-2032)
10    Europe Chronic Renal Failure Therapeutic Market Analysis
    10.1    United Kingdom
        10.1.1    Historical Trend (2018-2023) 
        10.1.2    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Historical Trend (2018-2023) 
        10.2.2    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Historical Trend (2018-2023) 
        10.3.2    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Historical Trend (2018-2023) 
        10.4.2    Forecast Trend (2024-2032)
    10.5   Others
11    Asia Pacific Chronic Renal Failure Therapeutic Market Analysis
    11.1    China
        11.1.1    Historical Trend (2018-2023) 
        11.1.2    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Historical Trend (2018-2023) 
        11.2.2    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Historical Trend (2018-2023) 
        11.3.2    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Historical Trend (2018-2023) 
        11.4.2    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.1    Historical Trend (2018-2023) 
        11.5.2    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America Chronic Renal Failure Therapeutic Market Analysis
    12.1    Brazil
        12.1.1    Historical Trend (2018-2023) 
        12.1.2    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Historical Trend (2018-2023) 
        12.2.2    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Historical Trend (2018-2023) 
        12.3.2    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa Chronic Renal Failure Therapeutic Market Analysis
    13.1    Saudi Arabia
        13.1.1    Historical Trend (2018-2023) 
        13.1.2    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Historical Trend (2018-2023) 
        13.2.2    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Historical Trend (2018-2023) 
        13.3.2    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Historical Trend (2018-2023) 
        13.4.2    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Competitive Landscape
    15.1    Market Structure
    15.2    Company Profiles
        15.2.1    Amgen Inc.
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
        15.2.2    AstraZeneca PLC
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
        15.2.3    Pfizer Inc.
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
        15.2.4    F. Hoffmann-La Roche Ltd
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
        15.2.5    Bayer AG
            15.2.5.1    Company Overview
            15.2.5.2    Product Portfolio
            15.2.5.3    Demographic Reach and Achievements
            15.2.5.4    Certifications
        15.2.6    Others
16    Key Trends and Developments in the Market


List of Key Figures and Tables

1.    Global Chronic Renal Failure Therapeutic Market: Key Industry Highlights, 2018 and 2032
2.    Global Chronic Renal Failure Therapeutic Historical Market: Breakup by Product (USD Million), 2018-2023
3.    Global Chronic Renal Failure Therapeutic Market Forecast: Breakup by Product (USD Million), 2024-2032
4.    Global Chronic Renal Failure Therapeutic Historical Market: Breakup by Region (USD Million), 2018-2023
5.    Global Chronic Renal Failure Therapeutic Market Forecast: Breakup by Region (USD Million), 2024-2032
6.    North America Chronic Renal Failure Therapeutic Historical Market: Breakup by Country (USD Million), 2018-2023
7.    North America Chronic Renal Failure Therapeutic Market Forecast: Breakup by Country (USD Million), 2024-2032
8.    Europe Chronic Renal Failure Therapeutic Historical Market: Breakup by Country (USD Million), 2018-2023
9.    Europe Chronic Renal Failure Therapeutic Market Forecast: Breakup by Country (USD Million), 2024-2032
10.    Asia Pacific Chronic Renal Failure Therapeutic Historical Market: Breakup by Country (USD Million), 2018-2023
11.    Asia Pacific Chronic Renal Failure Therapeutic Market Forecast: Breakup by Country (USD Million), 2024-2032
12.    Latin America Chronic Renal Failure Therapeutic Historical Market: Breakup by Country (USD Million), 2018-2023
13.    Latin America Chronic Renal Failure Therapeutic Market Forecast: Breakup by Country (USD Million), 2024-2032
14.    Middle East and Africa Chronic Renal Failure Therapeutic Historical Market: Breakup by Country (USD Million), 2018-2023
15.    Middle East and Africa Chronic Renal Failure Therapeutic Market Forecast: Breakup by Country (USD Million), 2024-2032
16.    Global Chronic Renal Failure Therapeutic Market Structure

Key Questions Answered in the Report

The global chronic renal failure therapeutic market is projected to grow at a CAGR of 6% between 2023 and 2032.

The major drivers of the industry, such as the growing incidences of chronic renal failure, changing lifestyle and consumption patterns, increasing geriatric population, and the growing technological advancements, are expected to aid the market growth.

The key market trends guiding the growth of the industry include the development of hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitors and the growing R&D activities.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Antihypertensive and antianaemia therapeutics, among others, are the leading products of chronic renal failure therapeutic in the industry.

The major players in the industry are Amgen Inc., AstraZeneca Plc, F. Hoffmann-La Roche Ltd., Bayer AG, and Pfizer Inc., among others.

Analyst Review

The global chronic renal failure therapeutic market is being driven by the rising prevalence of cardiovascular disorders, which leads to chronic renal failure. Aided by the development of novel oral HIF-PH inhibitors, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 6%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on products, the industry can be segmented into antihypertensive, and antianaemia therapeutics, among others. The major regional markets for chronic renal failure therapeutic are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Amgen Inc., AstraZeneca Plc, F. Hoffmann-La Roche Ltd., Bayer AG, and Pfizer Inc., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER